Medical Temigroup
Empresa española desarrolla los primeros hisopos por fabricación aditiva para PCR en el país Recientemente, la empresa española Temi Group Corporation (TGC), ha cerrado un acuerdo con el Hospital Virtual Valdecilla (HvV) para la fabricación con tecnología 3D de hisopos nasofaríngeos, piezas fundamentales en las pruebas PCR, que permiten detectar si una persona está infectada o no por coronavirus. Los hisopos permiten arrastrar fragmentos del material biológico necesario para identificar el Covid-19 cuando se realiza la prueba de diagnóstico mediante PCR. La planta de fabricación de TGC está ubicada en la provincia de Castellón, Valencia.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
11 to 50 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Medical Temigroup
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
Showing 1 of 2 verified contacts
Top roles at Medical Temigroup
2 distinct titles indexed · top 2 shown.
- 1auxiliar administrativo comercial
- 1secretario administrativo
Sign up to unlock all 2 contacts at Medical Temigroup
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Medical Temigroup
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.